Latest Breaking News On - Orphan drug designation - Page 1 : comparemela.com

Zydus Lifesciences completes enrolment for clinical trial of Usnoflast

Zydus Lifesciences completes enrolment for clinical trial of Usnoflast
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Zydus lifesciencesClinical pharmacology in drug developmentCenters for diseaseAmyotrophic lateral sclerosisDisease controlSlow vital capacityUlcerative colitisClinical pharmacologyOrphan drug designationCryopyrin associated periodic syndrome

Candel Therapeutics CAN-2409 For Pancreatic Cancer Gets FDA Orphan Drug Designation; Stock Up

Candel Therapeutics, Inc. (CADL), Thursday announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to CAN-2409, for the treatment of pancreatic cancer.

Candel therapeutics incDrug administrationCandel therapeuticsOrphan drug designationFast track designationOrphan drug designationFast track designationCandel therapeuticsAn 2409An 2409 plus valacyclovir

European Medicines Agency Grants Orphan Drug Designation to Tinengotinib for Biliary Tract Cancer

Tinengotinib has been awarded orphan drug designation from the European Medicines Agency for use in select patients with biliary tract cancer.

South koreaUnited statesTransthera sciences incEuropean unionEuropean medicines agencyTransthera sciencesNorth americaEuropean medicinesDthera sciencesKankeu fonkouaOrphan drug designationBiliary tract cancerPhase 3 first 308 study nct05948475Physicians choice of treatment vs tinengotinibFgfr mutated cholangiocarcinoma

UV1 Receives Orphan Drug Designation From EMA in Mesothelioma

The European Medicines Agency has granted orphan drug designation to UV1 in mesothelioma.

European medicines agencyFast trackEuropean medicines agencyCancer vaccine uv1Cancer vaccineCarlos de sousaPhase 2 nipu trialOrphan drug designation

Daewoong Pharmaceutical Co , Ltd : Daewoong Pharmaceutical s Bersiporocin Receives Orphan Drug Designation in Europe to Treat Idiopathic Pulmonary Fibrosis

Daewoong Pharmaceutical Co , Ltd : Daewoong Pharmaceutical s Bersiporocin Receives Orphan Drug Designation in Europe to Treat Idiopathic Pulmonary Fibrosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiStefan klotterClinical developmentEuropean molecular biology organizationEuropean medicines agencyKorea drug development fundOrphan drug designationBersiporocin receivesOrphan drug designationTreat idiopathic pulmonaryClinical development supportDaewoong pharmaceuticalDie performance strategieAssets sie